FINWIRES · TerminalLIVE
FINWIRES

Spotify's Investor Day Unveiled New Drivers of Future Growth and Profitability, Morgan Stanley Says

By

Spotify Technology (SPOT) introduced multiple new and meaningful drivers of growth and profitability at its investor day, showcasing its ability to capture incremental meaningful time spent, further revenue growth and drive towards 40% gross margins, Morgan Stanley said in a Friday note.

The company announced a deal with Universal Music Group, allowing fans to create covers and remixes of their favorite songs, Morgan Stanley noted, adding that this opens up additional revenue streams for Spotify as well as for labels and artists, along with a new path to drive discovery.

Spotify also announced a "Reserved by Spotify" feature that allows dedicated fans of an artist to have two concert tickets held just for them, which is further expected to differentiate the company's platform from the likes of other platforms, according to the note.

The company has outlined an opportunity to grow to 1 billion monthly active users by 2030, which will contribute to a mid-teens revenue compound annual growth rate, and 35% to 40% gross margins with 20% and above earnings before interest and taxes margins over that time frame, Morgan Stanley said.

Morgan Stanley raised its price target on the company's stock to $610 from $590 and maintained its overweight rating.

Price: $529.97, Change: $+40.04, Percent Change: +8.17%

Related Articles

Wire

Advance Auto Parts Turnaround Progressing, but Signs of Topline Momentum Needed, Morgan Stanley Says

Advance Auto Parts' (AAP) Q1 beat was encouraging, but while its turnaround story is progressing, investors still need to see sustained topline momentum and progress toward profitability and debt targets, Morgan Stanley said Thursday in a note.Q1 results reinforce confidence that the company's initiatives are gaining traction. However, execution risk still persists, especially as it navigates a more volatile consumer background, faces tougher comparisons in the second half, and pricing-related benefits roll off, according to the note.The analysts said they view the company's decision to maintain guidance as prudent, given near-term consumer volatility, typical "shoulder season" softness between tax refund spending and peak summer driving, and the start of lapping pricing-related tailwinds.The firm said it is keeping its 2026 EPS estimates unchanged and raising its 2027 estimates by 4%, reflecting the company's unchanged full-year guidance despite the topline and earnings beat, as well as improved visibility into an additional 100 basis points of margin expansion in 2027.Morgan Stanley kept an equal weight rating on Advance Auto Parts and raised the price target to $65 from $60.Price: $56.66, Change: $-1.96, Percent Change: -3.34%

$AAP
Wire

Zoom's AI Initiatives Starting to Pay Off, Wedbush Says

Zoom Communications' (ZM) investments in artificial intelligence have started to pay off while its customer experience portfolio continues to gain traction, Wedbush analysts said in a Friday note.Analysts said that Zoom's platform is showing momentum as its AI-driven approach resonates with enterprise customers looking to streamline operations.Wedbush said that in fiscal Q1, Zoom reported beats across the board while increasing its guidance for the full year.Wedbush raised its fiscal 2027 adjusted earnings per share estimate for the company to $5.98 from $5.79, slightly missing a FactSet consensus estimate of $6.01.Analysts retained an outperform rating on the stock and raised its price target to $120 from $110.Price: $108.29, Change: $+11.54, Percent Change: +11.93%

$ZM
Wire

Inspire Medical Systems Faces Coding Overhang, Estimate Risks, BofA Says

Inspire Medical Systems (INSP) faces risks to estimates and the stock is unlikely to perform without consistent clarity on coding pathways for centers, BofA Securities said in a Friday research note.The company's guidance assumes 2027 revenue will grow but it is difficult to predict a sustainable improvement until there is an official Category 1 code for the Inspire V leadless hypoglossal nerve stimulation system.The brokerage lowered its 2027 EPS estimate to $1 from $1.15 and its revenue forecast to $854 million from $863 million earlier. The EPS estimate for 2028 was trimmed down to $1.28 from $1.35 and the revenue forecast was cut to $907 million from $917 million.The company witnessed a decline in prior authorization submissions in Q1, but sees Q2 as the trough in growth, given early signs of PA volumes stabilizing and improving as centers gain coding experience, according to the note.BofA downgraded the stock to underperform from neutral and cut its price target to $39 per share from $53.Shares of Inspire Medical were down nearly 4% in Friday trading.Price: $43.07, Change: $-1.67, Percent Change: -3.73%

$INSP